60
Participants
Start Date
June 8, 2016
Primary Completion Date
January 26, 2021
Study Completion Date
January 26, 2021
KPT-9274
Niacin ER
Nivolumab
Georgetown University, Lombardi Comprehensive Cancer Center, Washington D.C.
Vanderbilt-Ingram Cancer Center, Nashville
Mayo Clinic Rochester, Rochester
MD Anderson Cancer Center, Houston
University of Colorado Cancer Center, Aurora
UCLA Health, Los Angeles
NYU-Laura & Isaac Perlmutter Cancer Center, New York
Princess Margaret Hospital, Toronto
Lead Sponsor
Karyopharm Therapeutics Inc
INDUSTRY